| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2406001 | Vaccine | 2009 | 4 Pages |
Abstract
Latin America is estimated to have 3637 cases of meningitis, 14,548 cases of bacteremia, 192,761–318,238 cases of pneumonia, and about 5.6 million cases of otitis media annually. Pneumococcal conjugate vaccines (PCVs) have proven to be effective in preventing paediatric pneumococcal disease. Monitoring serotypes and anti-microbial resistance in Latin American children by collecting clinical and epidemiological data at regular intervals is essential. It is important to identify and support systems for surveillance of invasive pneumococcal disease based on population to demonstrate the impact of PCVs. Surveillance should include pneumococcal disease in adults to estimate the indirect effects of the vaccine.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ciro A. de Quadros,